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SUNDAY, MARCH 15, 2015,
7:30AM–8:30AM
VIDEO B – PANCREAS/BILIARY
V-B.01 INTRAOPERATIVE AIR LEAK
TEST PREVENTS POST-HEPATECTOMY
BILE LEAK
R. W. Day, W. R. Burns, C. Conrad, J. Vauthey, T. A. Aloia
Department Of Surgical Oncology, The University Of Texas
MD Anderson Cancer Center, Houston, TEXAS
Background: After major liver resection, the incidence of
bile leak is reported at 4–10%. We have previously reported
that an intraoperative Air Leak Test (ALT) reduces the rate of
bile leak by five-fold with no additional morbidity or mor-
tality.
Purpose: Demonstrate the steps of an intraoperative ALT
following major liver resection.
Results: A 29 year-old man presented with T3N1M1 rectal
cancer and synchronous liver metastases. There were two
right liver metastases, one at the right portal junction neces-
sitating right hepatectomy. After neoadjuvant FOLFOX and
bevacizumab chemotherapy, chemoradiotherapy to his
primary rectal cancer, and abdominoperineal resection, he
presented for liver resection. His liver metastases had radio-
graphically responded with CEA decrease from 8.5 to 2.3 ng/
mL. The functional liver remnant volume was calculated to
be 31%. The video briefly describes key components of the
right hepatectomy including extrahepatic vascular inflow
control, two-surgeon technique for hepatic parenchymal
transection, and intrahepatic stapled division of the right bile
duct. It then details the sequential steps of the ALT including
cannulation of the cystic duct, Doppler of intrahepatic vas-
cular flow, manual occlusion of the bile duct, injection of air
under ultrasound visualization to confirm patency of the
biliary confluence, and repeated injection of air to identify
and oversew occult open bile ducts. At the completion of the
ALT, the patient had no air leaks and no drain was placed. He
experienced an uneventful recovery.
Conclusion: For patients undergoing major hepatectomy,
intraoperative ALT is a rapid, safe, and inexpensive means to
decrease the incidence of post-operative bile leak.
V-B.02 MINIMALLY INVASIVE PARTIAL
RIGHT HEPATECTOMY WITH
TRANSDIAPHRAGMATIC RIGHT
LOWER LOBE LUNG RESECTION FOR
COLORECTAL METASTASES
R. W. Day1, R. J. Mehran2, N. De Rosa1, C. Conrad1,
T. L. Moon3, J. Vauthey1, T. A. Aloia1
1Department Of Surgical Oncology, The University Of
Texas MD Anderson Cancer Center, Houston, TEXAS;
2Department Of Thoracic And Cardiovascular Surgery,
The University Of Texas MD Anderson, Houston, TEXAS;
3Department Of Anesthesiology And Perioperative
Medicine, The University Of Texas MD Anderson,
Houston, TEXAS
Background: Patients with metastatic colorectal disease to
the liver and lungs have improved long-term outcomes when
both sites of metastases are resected. The main obstacle to
simultaneous resection is the additional morbidity of a tho-
racic incision. We have recently published an experience
with open hepatectomy and transdiaphragmatic lung resec-
tion, demonstrating the feasibility and safety of this
approach.
Purpose: In an effort to further improve outcomes we inves-
tigated the ability to perform the simultaneous procedure
using minimally invasive techniques.
Results: A 40 year-old woman with pT1N0 colon cancer
status post low anterior resection represented with an
elevated carcinoembryonic antigen (CEA = 4.5 ng/mL).
Imaging demonstrated three liver lesions, biopsy positive for
metastasis and one right lower lobe pulmonary lesion.
Preoperatively, she received three cycles of FOLFOX/
bevacizumab treatment and one cycle of FOLFOX alone
with radiological and biochemical response (CEA = 2.5 ng/
mL). In this video we demonstrate the key components of her
hand-assisted, laparoscopic simultaneous multifocal liver
and lung tumor resection including the use of a rubber band
retraction technique, resection of a disappeared 3 mm lesion,
and the transdiaphragmatic lung resection with EndoStitch™
diaphragm closure. Final pathology confirmed margin nega-
tive resection of all 4 tumors. The patient was discharged
from the hospital on POD #4 with no medical or surgical
complications and a rapid return to normal function, as meas-
ured by a validated quality of life assessment tool.
Conclusion: In carefully selected patients with metastatic
colorectal cancer, minimally invasive transdiaphragmatic
approaches to lung resection simultaneous with liver resec-
tion are technically feasible and safe to perform.
V-B.03 LAPAROSCOPIC MAJOR
ARTERIAL RESECTION DURING
PANCREATICODUODENECTOMY
B. Franssen, M. Kendrick
Mayo Clinic, Rochester, MN
With recent improvements in multimodality treatment for
borderline and locally advanced pancreatic cancer, major
vascular resection during pancreatic surgery has become
more frequent. Although portal vein and SMV resection in
both open and laparoscopic pancreaticoduodenectomy (PD)
has been previously described, the feasibility of major arte-
rial resection in laparoscopic pancreatectomy has not been
established. While major arterial resection remains contro-
versial, it is performed in our center in very select patients in
order to achieve an R0 resection during PD. The aim of this
video presentation is to demonstrate technical aspects and
plausibility of a common hepatic artery resection and recon-
struction in combination with a portal vein resection in a
patient undergoing laparoscopic PD with a radiographically
stable ductal adenocarcinoma diagnosed two years prior to
surgery.
72 Abstracts
© 2015 The Authors
HPB © 2015 Americas Hepato-Pancreato-Biliary Association HPB 2015, 17 (Suppl. 1), 1–80
V-B.04 MODIFIED ROBOTIC APPLEBY
PROCEDURE WITH LEFT
NEPHRECTOMY AND
ADRENALECTOMY FOR
LOCALLY ADVANCED DISTAL
PANCREATIC CANCER
M. Radomski, A. Zureikat, H. Zeh, M. Hogg
University Of Pittsburgh, Pittsburgh, PA
Patients presenting with Stage III pancreatic adenocarcinoma
involving the distal pancreas and celiac axis have historically
been treated by nonsurgical means. However, almost a third
of these patients will die without metastatic disease suggest-
ing that aggressive surgical resection involving visceral vas-
cular structures may offer a survival advantage. Appleby first
described resection of the celiac axis for gastric cancer. We
have extended this technique to include stage III distal pan-
creatic adenocarcinoma involving the celiac axis without evi-
dence of metastatic disease via a combined laparoscopic and
robotic approach. We describe a robotic distal pancreatec-
tomy, splenectomy, left nephrectomy, and left adrenalectomy
in a 65 year old female patient with pancreatic adenocarci-
noma involving the distal pancreas without evidence of
distant metastatic disease. She previously underwent six
cycles neoadjuvant chemotherapy with gemcitabine and
abraxane in which she had a good response with normalizing
CA19-9 values. Her postoperative course was complicated
by gastric ischemia which was treated with short course of
total parenteral nutrition, and a portal vein thrombus treated
with subcutaneous low molecular weight heparin. Her
pathology showed a 4.0 cm moderately differentiated adeno-
carcinoma with negative margins and twenty-six lymph
nodes negative for disease. She was discharged home on
postoperative day 25 and started on adjuvant chemotherapy
with gemcitabine and abraxane on postoperative day 76.
V-B.05 ROBOTIC
PANCREATICODUODENECTOMY WITH
PORTAL VEIN RESECTION AND PATCH
VENOPLASTY
M. Girgis, M. Hogg, H. Zeh, A. Zureikat
University Of Pittsburgh School Of Medicine, Pittsburgh,
PA
Introduction: Robotic pancreaticoduodenectomy is safe
and feasible for resectable pancreatic head adenocarcinoma.
Vascular resection during pancreaticoduodenectomy for
borderline resectable PDAC may be associated with slightly
increased morbidity but provides good oncologic outcomes.
We describe a robotic pancreaticoduodenectomy with
planned portal vein resection and patch venoplasty in a
patient with borderline resectable pancreas cancer.
Methods: This patient’s operation was recorded by the Da
Vinci Surgical System. The file footage was compiled and
edited. The patient’s consent was obtained.
Results: This is the case of a 57-year-old patient with
locally advanced pancreas cancer. He underwent 6 cycles of
neoadjuvant chemotherapy. Restaging CT scan showed
down-staging of the tumor to borderline resectable status.
The procedure was completed robotically in 452 minutes
with an estimated blood loss of 900 ml. A large 4 cm partial
portal vein resection was performed with reconstruction
using bovine pericardium in the form of a patch venoplasty.
Final pathology revealed a 2.9 cm tumor with 4/37 nodes
positive. He recovered uneventfully from the surgery and was
discharged from the hospital on postoperative day 6. Within
45 days of surgery, he had initiated adjuvant chemotherapy.
Conclusions: We describe a robotic portal vein resection
and reconstruction with patch venoplasty for borderline
resectable PDAC. We were able to complete the procedure
safely and in a timely manner with minimal morbidity.
SUNDAY, MARCH 15, 2015,
8:30AM–10:30AM
LONG ORAL J – LIVER
PERIOPERATIVE/TECHNIQUES
LO-J.01 ELEVATED INR
INDEPENDENTLY PREDICTS MAJOR
COMPLICATIONS FOLLOWING MAJOR
HEPATECTOMY
J. N. Leal, T. P. Kingham, P. J. Allen, R. P. DeMatteo,
W. R. Jarnagin, M. I. D’Angelica
Memorial Sloan Kettering Cancer Center, New York, NY
Background: The impact of major hepatectomy on
hemostasis is poorly characterized and accuracy of INR as an
indicator of coagulation status in the peri-operative setting
is unknown. This study aimed to characterize post-
hepatectomy hemostatic profiles and to evaluate subsequent
impact on clinical outcomes.
Methods: All patients undergoing major hepatectomy
between 2001–2012 were identified from a prospective data-
base. Clinicopathologic and blood product transfusion data
were extracted. Post-operative hemostatic profiles were
analyzed with respect to plasma transfusion and major com-
plications.
Results: 961 patients were identified. The mean number
of Couinaud segments resected was 4.3(+/−0.85).Post-
operatively peak INR was 1.50 +/− 0.26, platelet nadir
166.1 +/− 61.7 K/mcL, and hemoglobin nadir 9.5 +/− 1.34 g/
dL. INR ≥1.8 occurred in 152 (16%) patients. Major bleeding
complication rates in the INR ≥1.8 group were not different
from INR <1.8 group (0.7% vs. 0.8%, p = 0.90). Alterna-
tively, major complication rates were significantly higher
(37% INR ≥1.8 vs. 17% INR <1.8, p < 0.0001). Among the
INR ≥1.8 group, plasma was transfused in 66% of cases and
was not associated with a significant change in major com-
plication rates (40% in peak INR ≥1.8 with plasma vs. 30%
in peak INR ≥1.8 without plasma, p = 0.30). On multivariate
analysis, including standard variables, peak INR ≥1.8 was
independently associated with major complications (OR
2.48, 95% CI 1.64–3.74, p < 0.0001) while FFP transfusion
was not (OR 1.35 95% CI 0.90–2.05, p = 0.152).
Conclusions: Elevated INR following major hepatectomy
does not increase the risk of post operative hemorrhage but
rather portends increased overall morbidity that is not miti-
gated by FFP transfusion.
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